{"id":"tp-49990","type":"article-newspaper","title":"Bio-Rad Narrows 2026 Operating Margin Target to Upper Half of Range","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/49990","datePublished":"2026-11-06T09:34:40.000Z","dateModified":"2026-11-06T09:34:40.000Z","language":"en","abstract":"The company maintained its non-GAAP gross-margin range of 53% to 54% and kept its currency-neutral revenue outlook.","section":"Business","references":[{"title":"third-quarter results","url":"https://www.tokenpost.com/news/business/49605"}]}